Logo image of PKI

PERKINELMER INC (PKI) Stock Overview

USA - NYSE:PKI - US7140461093 - Common Stock

115.24 USD
-1.06 (-0.91%)
Last: 5/15/2023, 8:04:00 PM
115.24 USD
0 (0%)
After Hours: 5/15/2023, 8:04:00 PM

PKI Key Statistics, Chart & Performance

Key Statistics
Market Cap14.57B
Revenue(TTM)4.57B
Net Income(TTM)746.14M
Shares126.41M
Float125.94M
52 Week High170
52 Week Low113.46
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)7.94
PE14.51
Fwd PE22.11
Earnings (Next)07-31 2023-07-31/bmo
IPO1965-07-06
Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences


PKI short term performance overview.The bars show the price performance of PKI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -5 -10 -15

PKI long term performance overview.The bars show the price performance of PKI in the last 1, 2 and 3 years. 1 year 2 years 3 years -5 -10 -15 -20

The current stock price of PKI is 115.24 USD. In the past month the price decreased by -15.23%. In the past year, price decreased by -21.46%.

PERKINELMER INC / PKI Daily stock chart

PKI Latest News, Press Relases and Analysis

PKI Competitors/Peers

The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
TMO THERMO FISHER SCIENTIFIC INC 25.17 212.89B
DHR DANAHER CORP 28.67 158.25B
BRKRP BRUKER CORP - BRKR 6 3/8 09/01/28 144.36 47.09B
A AGILENT TECHNOLOGIES INC 26.9 41.56B
IQV IQVIA HOLDINGS INC 18.96 36.96B
MTD METTLER-TOLEDO INTERNATIONAL 34.71 29.25B
WAT WATERS CORP 28.76 20.94B
WST WEST PHARMACEUTICAL SERVICES 40.63 20.65B
MEDP MEDPACE HOLDINGS INC 41.71 16.76B
TEM TEMPUS AI INC N/A 15.91B
ILMN ILLUMINA INC 24.12 15.42B
ICLR ICON PLC 13.8 14.16B

About PKI

Company Profile

PKI logo image PerkinElmer, Inc. engages in the provision of products, services, and solutions for diagnostics, food, environmental, life sciences, and applied markets. The company is headquartered in Waltham, Massachusetts and currently employs 16,700 full-time employees. The firm operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides products and services targeted towards the life sciences and applied markets. The Diagnostics segment develops diagnostics, tools and applications focused on clinically oriented customers, especially within the reproductive health, immunodiagnostics and applied genomics markets. Its products and services for Discovery & Analytical Solutions applications include The Opera Phenix Plus high-content screening system, The Operetta CLS high-content analysis system, The MuviCyte live-cell imaging system, and The Signals Image Artist. Its products and services for Diagnostics applications include The DELFIA Xpress screening platform, The Specimen Gate informatics data management solution and The DELFIA Xpress sFlt-1 kit.

Company Info

PERKINELMER INC

940 Winter Street

Waltham MASSACHUSETTS 02451 US

CEO: Prahlad Singh

Employees: 16700

PKI Company Website

Phone: 17816635776.0

PERKINELMER INC / PKI FAQ

What does PERKINELMER INC do?

PerkinElmer, Inc. engages in the provision of products, services, and solutions for diagnostics, food, environmental, life sciences, and applied markets. The company is headquartered in Waltham, Massachusetts and currently employs 16,700 full-time employees. The firm operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides products and services targeted towards the life sciences and applied markets. The Diagnostics segment develops diagnostics, tools and applications focused on clinically oriented customers, especially within the reproductive health, immunodiagnostics and applied genomics markets. Its products and services for Discovery & Analytical Solutions applications include The Opera Phenix Plus high-content screening system, The Operetta CLS high-content analysis system, The MuviCyte live-cell imaging system, and The Signals Image Artist. Its products and services for Diagnostics applications include The DELFIA Xpress screening platform, The Specimen Gate informatics data management solution and The DELFIA Xpress sFlt-1 kit.


What is the current price of PKI stock?

The current stock price of PKI is 115.24 USD. The price decreased by -0.91% in the last trading session.


What is the dividend status of PERKINELMER INC?

PKI does not pay a dividend.


What is the ChartMill technical and fundamental rating of PKI stock?

PKI has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 4 out of 10.


Should I buy PKI stock?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on PKI.


Can you provide the upcoming earnings date for PERKINELMER INC?

PERKINELMER INC (PKI) will report earnings on 2023-07-31, before the market open.


PKI Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

PKI Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to PKI. While PKI seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

PKI Financial Highlights

Over the last trailing twelve months PKI reported a non-GAAP Earnings per Share(EPS) of 7.94. The EPS decreased by -30.47% compared to the year before.


Industry RankSector Rank
PM (TTM) 16.32%
ROA 5.28%
ROE 10.11%
Debt/Equity 0.53
Chartmill High Growth Momentum
EPS Q2Q%-33.59%
Sales Q2Q%-27.89%
EPS 1Y (TTM)-30.47%
Revenue 1Y (TTM)-3.37%

PKI Forecast & Estimates

20 analysts have analysed PKI and the average price target is 159.39 USD. This implies a price increase of 38.31% is expected in the next year compared to the current price of 115.24.

For the next year, analysts expect an EPS growth of -34.36% and a revenue growth -31.32% for PKI


Analysts
Analysts73
Price Target159.39 (38.31%)
EPS Next Y-34.36%
Revenue Next Year-31.32%

PKI Ownership

Ownership
Inst Owners86.56%
Ins Owners0.81%
Short Float %N/A
Short RatioN/A